Ovarian cancer-specific BRCA-like copy-number aberration classifiers detect mutations associated with homologous recombination deficiency in the AGO-TR1 trial

Purpose: Previously, we developed breast cancer BRCA1-like and BRCA2-like copy-number profile shrunken centroid classifiers predictive for mutation status and response to therapy, targeting homologous recombination deficiency (HRD). Therefore, we investigated BRCA1- and BRCA2-like classification in...

Full description

Saved in:
Bibliographic Details
Main Authors: Schouten, Philip (Author) , Richters, Lisa (Author) , Vis, Daniel J. (Author) , Kommoss, Stefan (Author) , Dijk, Ewald van (Author) , Ernst, Corinna (Author) , Kluin, Roelof J. C. (Author) , Marmé, Frederik (Author) , Lips, Esther H. (Author) , Schmidt, Sandra (Author) , Scheerman, Esther (Author) , Prieske, Katharina (Author) , Deurzen, Carolien H. M. van (Author) , Burges, Alexander (Author) , Ewing-Graham, Patricia C. (Author) , Dietrich, Dimo (Author) , Jager, Agnes (Author) , Gregorio, Nikolaus de (Author) , Hauke, Jan (Author) , Bois, Andreas du (Author) , Nederlof, Petra M. (Author) , Wessels, Lodewyk F. (Author) , Hahnen, Eric (Author) , Harter, Philipp (Author) , Linn, Sabine C. (Author) , Schmutzler, Rita K. (Author)
Format: Article (Journal)
Language:English
Published: September 30, 2021
In: Clinical cancer research
Year: 2021, Volume: 27, Issue: 23, Pages: 6559-6569
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-21-1673
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/1078-0432.CCR-21-1673
Verlag, lizenzpflichtig, Volltext: https://clincancerres.aacrjournals.org/content/27/23/6559
Get full text
Author Notes:Philip C. Schouten, Lisa Richters, Daniel J. Vis, Stefan Kommoss, Ewald van Dijk, Corinna Ernst, Roelof J.C. Kluin, Frederik Marmé, Esther H. Lips, Sandra Schmidt, Esther Scheerman, Katharina Prieske, Carolien H.M. van Deurzen, Alexander Burges, Patricia C. Ewing-Graham, Dimo Dietrich, Agnes Jager, Nikolaus de Gregorio, Jan Hauke, Andreas du Bois, Petra M. Nederlof, Lodewyk F. Wessels, Eric Hahnen, Philipp Harter, Sabine C. Linn, and Rita K. Schmutzler

MARC

LEADER 00000caa a2200000 c 4500
001 1786759101
003 DE-627
005 20220820112252.0
007 cr uuu---uuuuu
008 220121s2021 xx |||||o 00| ||eng c
024 7 |a 10.1158/1078-0432.CCR-21-1673  |2 doi 
035 |a (DE-627)1786759101 
035 |a (DE-599)KXP1786759101 
035 |a (OCoLC)1341438984 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schouten, Philip  |e VerfasserIn  |0 (DE-588)1210713683  |0 (DE-627)169867600X  |4 aut 
245 1 0 |a Ovarian cancer-specific BRCA-like copy-number aberration classifiers detect mutations associated with homologous recombination deficiency in the AGO-TR1 trial  |c Philip C. Schouten, Lisa Richters, Daniel J. Vis, Stefan Kommoss, Ewald van Dijk, Corinna Ernst, Roelof J.C. Kluin, Frederik Marmé, Esther H. Lips, Sandra Schmidt, Esther Scheerman, Katharina Prieske, Carolien H.M. van Deurzen, Alexander Burges, Patricia C. Ewing-Graham, Dimo Dietrich, Agnes Jager, Nikolaus de Gregorio, Jan Hauke, Andreas du Bois, Petra M. Nederlof, Lodewyk F. Wessels, Eric Hahnen, Philipp Harter, Sabine C. Linn, and Rita K. Schmutzler 
264 1 |c September 30, 2021 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.01.2022 
520 |a Purpose: Previously, we developed breast cancer BRCA1-like and BRCA2-like copy-number profile shrunken centroid classifiers predictive for mutation status and response to therapy, targeting homologous recombination deficiency (HRD). Therefore, we investigated BRCA1- and BRCA2-like classification in ovarian cancer, aiming to acquire classifiers with similar properties as those in breast cancer. - Experimental Design: We analyzed DNA copy-number profiles of germline BRCA1- and BRCA2-mutant ovarian cancers and control tumors and observed that existing breast cancer classifiers did not sufficiently predict mutation status. Hence, we trained new shrunken centroid classifiers on this set and validated them in the independent The Cancer Genome Atlas dataset. Subsequently, we assessed BRCA1/2-like classification and obtained germline and tumor mutation and methylation status of cancer predisposition genes, among them several involved in HR repair, of 300 ovarian cancer samples derived from the consecutive cohort trial AGO-TR1 (NCT02222883). - Results: The detection rate of the BRCA1-like classifier for BRCA1 mutations and promoter hypermethylation was 95.6%. The BRCA2-like classifier performed less accurately, likely due to a smaller training set. Furthermore, three quarters of the BRCA1/2-like tumors could be explained by (epi)genetic alterations in BRCA1/2, germline RAD51C mutations and alterations in other genes involved in HR. Around half of the non-BRCA-mutated ovarian cancer cases displayed a BRCA-like phenotype. - Conclusions: The newly trained classifiers detected most BRCA-mutated and methylated cancers and all tumors harboring a RAD51C germline mutations. Beyond that, we found an additional substantial proportion of ovarian cancers to be BRCA-like. 
700 1 |a Richters, Lisa  |e VerfasserIn  |4 aut 
700 1 |a Vis, Daniel J.  |e VerfasserIn  |4 aut 
700 1 |a Kommoss, Stefan  |e VerfasserIn  |4 aut 
700 1 |a Dijk, Ewald van  |e VerfasserIn  |4 aut 
700 1 |a Ernst, Corinna  |e VerfasserIn  |4 aut 
700 1 |a Kluin, Roelof J. C.  |e VerfasserIn  |4 aut 
700 1 |a Marmé, Frederik  |d 1974-  |e VerfasserIn  |0 (DE-588)132561972  |0 (DE-627)52394893X  |0 (DE-576)299226549  |4 aut 
700 1 |a Lips, Esther H.  |e VerfasserIn  |4 aut 
700 1 |a Schmidt, Sandra  |e VerfasserIn  |4 aut 
700 1 |a Scheerman, Esther  |e VerfasserIn  |4 aut 
700 1 |a Prieske, Katharina  |e VerfasserIn  |4 aut 
700 1 |a Deurzen, Carolien H. M. van  |e VerfasserIn  |4 aut 
700 1 |a Burges, Alexander  |e VerfasserIn  |4 aut 
700 1 |a Ewing-Graham, Patricia C.  |e VerfasserIn  |4 aut 
700 1 |a Dietrich, Dimo  |e VerfasserIn  |4 aut 
700 1 |a Jager, Agnes  |e VerfasserIn  |4 aut 
700 1 |a Gregorio, Nikolaus de  |e VerfasserIn  |4 aut 
700 1 |a Hauke, Jan  |e VerfasserIn  |4 aut 
700 1 |a Bois, Andreas du  |e VerfasserIn  |4 aut 
700 1 |a Nederlof, Petra M.  |e VerfasserIn  |4 aut 
700 1 |a Wessels, Lodewyk F.  |e VerfasserIn  |4 aut 
700 1 |a Hahnen, Eric  |e VerfasserIn  |4 aut 
700 1 |a Harter, Philipp  |e VerfasserIn  |4 aut 
700 1 |a Linn, Sabine C.  |e VerfasserIn  |4 aut 
700 1 |a Schmutzler, Rita K.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Clinical cancer research  |d Philadelphia, Pa. [u.a.] : AACR, 1995  |g 27(2021), 23, Seite 6559-6569  |h Online-Ressource  |w (DE-627)325489971  |w (DE-600)2036787-9  |w (DE-576)094502234  |x 1557-3265  |7 nnas  |a Ovarian cancer-specific BRCA-like copy-number aberration classifiers detect mutations associated with homologous recombination deficiency in the AGO-TR1 trial 
773 1 8 |g volume:27  |g year:2021  |g number:23  |g pages:6559-6569  |g extent:11  |a Ovarian cancer-specific BRCA-like copy-number aberration classifiers detect mutations associated with homologous recombination deficiency in the AGO-TR1 trial 
856 4 0 |u https://doi.org/10.1158/1078-0432.CCR-21-1673  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://clincancerres.aacrjournals.org/content/27/23/6559  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220121 
993 |a Article 
994 |a 2021 
998 |g 132561972  |a Marmé, Frederik  |m 132561972:Marmé, Frederik  |d 50000  |d 60000  |d 61300  |e 50000PM132561972  |e 60000PM132561972  |e 61300PM132561972  |k 0/50000/  |k 0/60000/  |k 1/60000/61300/  |p 8 
999 |a KXP-PPN1786759101  |e 4040687108 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"11 S."}],"language":["eng"],"recId":"1786759101","id":{"doi":["10.1158/1078-0432.CCR-21-1673"],"eki":["1786759101"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"disp":"Ovarian cancer-specific BRCA-like copy-number aberration classifiers detect mutations associated with homologous recombination deficiency in the AGO-TR1 trialClinical cancer research","part":{"issue":"23","year":"2021","text":"27(2021), 23, Seite 6559-6569","pages":"6559-6569","volume":"27","extent":"11"},"corporate":[{"display":"American Association for Cancer Research","role":"isb"}],"language":["eng"],"recId":"325489971","id":{"zdb":["2036787-9"],"issn":["1557-3265"],"eki":["325489971"]},"name":{"displayForm":["American Association for Cancer Research"]},"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"title":[{"title":"Clinical cancer research","title_sort":"Clinical cancer research"}],"pubHistory":["1.1995 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1995","publisher":"AACR","dateIssuedDisp":"1995-","publisherPlace":"Philadelphia, Pa. [u.a.]"}]}],"name":{"displayForm":["Philip C. Schouten, Lisa Richters, Daniel J. Vis, Stefan Kommoss, Ewald van Dijk, Corinna Ernst, Roelof J.C. Kluin, Frederik Marmé, Esther H. Lips, Sandra Schmidt, Esther Scheerman, Katharina Prieske, Carolien H.M. van Deurzen, Alexander Burges, Patricia C. Ewing-Graham, Dimo Dietrich, Agnes Jager, Nikolaus de Gregorio, Jan Hauke, Andreas du Bois, Petra M. Nederlof, Lodewyk F. Wessels, Eric Hahnen, Philipp Harter, Sabine C. Linn, and Rita K. Schmutzler"]},"note":["Gesehen am 21.01.2022"],"person":[{"role":"aut","given":"Philip","family":"Schouten","display":"Schouten, Philip"},{"role":"aut","display":"Richters, Lisa","given":"Lisa","family":"Richters"},{"role":"aut","display":"Vis, Daniel J.","family":"Vis","given":"Daniel J."},{"role":"aut","given":"Stefan","family":"Kommoss","display":"Kommoss, Stefan"},{"family":"Dijk","given":"Ewald van","display":"Dijk, Ewald van","role":"aut"},{"role":"aut","display":"Ernst, Corinna","family":"Ernst","given":"Corinna"},{"role":"aut","family":"Kluin","given":"Roelof J. C.","display":"Kluin, Roelof J. C."},{"given":"Frederik","family":"Marmé","display":"Marmé, Frederik","role":"aut"},{"role":"aut","display":"Lips, Esther H.","family":"Lips","given":"Esther H."},{"role":"aut","display":"Schmidt, Sandra","given":"Sandra","family":"Schmidt"},{"role":"aut","display":"Scheerman, Esther","family":"Scheerman","given":"Esther"},{"role":"aut","family":"Prieske","given":"Katharina","display":"Prieske, Katharina"},{"display":"Deurzen, Carolien H. M. van","family":"Deurzen","given":"Carolien H. M. van","role":"aut"},{"display":"Burges, Alexander","given":"Alexander","family":"Burges","role":"aut"},{"role":"aut","family":"Ewing-Graham","given":"Patricia C.","display":"Ewing-Graham, Patricia C."},{"given":"Dimo","family":"Dietrich","display":"Dietrich, Dimo","role":"aut"},{"given":"Agnes","family":"Jager","display":"Jager, Agnes","role":"aut"},{"role":"aut","display":"Gregorio, Nikolaus de","family":"Gregorio","given":"Nikolaus de"},{"role":"aut","given":"Jan","family":"Hauke","display":"Hauke, Jan"},{"display":"Bois, Andreas du","given":"Andreas du","family":"Bois","role":"aut"},{"role":"aut","display":"Nederlof, Petra M.","family":"Nederlof","given":"Petra M."},{"display":"Wessels, Lodewyk F.","given":"Lodewyk F.","family":"Wessels","role":"aut"},{"given":"Eric","family":"Hahnen","display":"Hahnen, Eric","role":"aut"},{"role":"aut","display":"Harter, Philipp","given":"Philipp","family":"Harter"},{"given":"Sabine C.","family":"Linn","display":"Linn, Sabine C.","role":"aut"},{"family":"Schmutzler","given":"Rita K.","display":"Schmutzler, Rita K.","role":"aut"}],"title":[{"title_sort":"Ovarian cancer-specific BRCA-like copy-number aberration classifiers detect mutations associated with homologous recombination deficiency in the AGO-TR1 trial","title":"Ovarian cancer-specific BRCA-like copy-number aberration classifiers detect mutations associated with homologous recombination deficiency in the AGO-TR1 trial"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"September 30, 2021","dateIssuedKey":"2021"}]} 
SRT |a SCHOUTENPHOVARIANCAN3020